331 related articles for article (PubMed ID: 12821538)
21. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
22. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Lima e Silva R; Hylton D; Rudge JS; Wiegand SJ; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):241-8. PubMed ID: 12652651
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.
Seno H; Oshima M; Ishikawa TO; Oshima H; Takaku K; Chiba T; Narumiya S; Taketo MM
Cancer Res; 2002 Jan; 62(2):506-11. PubMed ID: 11809702
[TBL] [Abstract][Full Text] [Related]
24. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation.
Haider A; Lee I; Grabarek J; Darzynkiewicz Z; Ferreri NR
Circulation; 2003 Aug; 108(8):1015-21. PubMed ID: 12912810
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
Hui AY; Dannenberg AJ; Sung JJ; Subbaramaiah K; Du B; Olinga P; Friedman SL
J Hepatol; 2004 Aug; 41(2):251-8. PubMed ID: 15288474
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
27. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
[TBL] [Abstract][Full Text] [Related]
29. Cyclooxygenase-2-derived prostaglandin E2 is involved in vascular endothelial growth factor production in interleukin-1alpha-stimulated human periodontal ligament cells.
Bando Y; Noguchi K; Kobayashi H; Yoshida N; Ishikawa I; Izumi Y
J Periodontal Res; 2009 Jun; 44(3):395-401. PubMed ID: 19210337
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
Shimamura M; Hazato T; Ashino H; Yamamoto Y; Iwasaki E; Tobe H; Yamamoto K; Yamamoto S
Biochem Biophys Res Commun; 2001 Nov; 289(1):220-4. PubMed ID: 11708802
[TBL] [Abstract][Full Text] [Related]
31. Elevation of both cyclooxygenase-2 and prostaglandin E2 receptor EP3 expressions in rat placenta after uterine artery ischemia-reperfusion.
Yamazaki K; Endo T; Kitajima Y; Manase K; Nagasawa K; Honnma H; Hayashi T; Kudo R; Saito T
Placenta; 2006; 27(4-5):395-401. PubMed ID: 15990166
[TBL] [Abstract][Full Text] [Related]
32. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
Gendron RL; Good WV; Adams LC; Paradis H
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
[TBL] [Abstract][Full Text] [Related]
33. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
34. Tissue kallikrein inhibits retinal neovascularization via the cleavage of vascular endothelial growth factor-165.
Nakamura S; Morimoto N; Tsuruma K; Izuta H; Yasuda Y; Kato N; Ikeda T; Shimazawa M; Hara H
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1041-8. PubMed ID: 21293011
[TBL] [Abstract][Full Text] [Related]
35. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.
Ozaki H; Seo MS; Ozaki K; Yamada H; Yamada E; Okamoto N; Hofmann F; Wood JM; Campochiaro PA
Am J Pathol; 2000 Feb; 156(2):697-707. PubMed ID: 10666398
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
[TBL] [Abstract][Full Text] [Related]
37. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer.
Chu J; Lloyd FL; Trifan OC; Knapp B; Rizzo MT
Mol Cancer Ther; 2003 Jan; 2(1):1-7. PubMed ID: 12533667
[TBL] [Abstract][Full Text] [Related]
38. Possible role of cyclooxygenase II in the acquisition of ovarian luteal function in rodents.
Sakurai T; Tamura K; Okamoto S; Hara T; Kogo H
Biol Reprod; 2003 Sep; 69(3):835-42. PubMed ID: 12724285
[TBL] [Abstract][Full Text] [Related]
39. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
40. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]